A 57-year-old gentleman with a past medical history significant for Hodgkin's lymphoma in 1977 (which required splenectomy, radiation therapy, and chemotherapy) was incidentally found to have a large left lobe liver mass in July 2008 while he was undergoing computed tomography imaging for presumed n
Liver transplant for the treatment of giant hepatic hemangioma
✍ Scribed by Álvaro Antônio Bandeira Ferraz; Marcelo José Antunes Sette; Marcelo Maia; Edmundo Pessoa de Almeida Lopes; Michelle Maria Gonsalves Godoy; André Tavares da Silva Petribú; Marconi Meira; Otávio da Rosa Borges
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 159 KB
- Volume
- 10
- Category
- Article
- ISSN
- 1527-6465
- DOI
- 10.1002/lt.20250
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
mata can be safely used for transplantation. We advocate backtable resection of these tumors so to avoid further complications.
Recurrent hepatitis C after liver transplantation is a universal phenomenon. Graft reinfection occurs rapidly; once it is established, allograft cirrhosis and decompensation rapidly ensue in many patients. Treatment with pegylated interferon plus ribavirin is the standard of care among nontransplant
Hepatitis C recurrence after liver transplantation is a serious problem, leading to increased graft loss and morbidity in some individuals. Treatment with interferon and other agents is controversial and not highly efficacious. The use of an effective antiviral agent to reduce or eliminate viral bur
Three cases of giant hemangioma of the liver associated with clinical and laboratory signs of inflammatory process, including low-grade fever, weight loss, abdominal pain, accelerated erythrocyte sedimentation rate, anemia, thrombocytosis, and increased fibrinogen level with normal white blood cell